Trevi Therapeutics (TRVI) Earnings Date, Estimates & Call Transcripts → Dave Ramsey Shocks Millions With US Dollar Lunacy (From American Hartford Gold Group) (Ad) Free TRVI Stock Alerts $2.91 -0.03 (-1.02%) (As of 02:39 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryLatest Earnings DateMay. 7ConfirmedConsensus EPS (May. 7) -$0.09 Listen to Call Get Trevi Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for TRVI and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueTRVI Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TRVI Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Birch GoldThe Sneaky IRS Tax Law that's Sweeping the U.S.In the years immediately following 2008-09, as the economy stagnated, gold exploded in value. Today, Goldman Sachs is telling its clients that gold may reach $2,250 within the next few years. Don't miss your chance to diversify your savings.Request your info kit on gold now Trevi Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.09)($0.09)($0.09)Q2 20241($0.11)($0.11)($0.11)Q3 20241($0.12)($0.12)($0.12)Q4 20241($0.13)($0.13)($0.13)FY 20244($0.45)($0.45)($0.45)TRVI Earnings Date and InformationTrevi Therapeutics last issued its quarterly earnings results on May 7th, 2024. The reported $0.00 earnings per share for the quarter, beating analysts' consensus estimates of ($0.09) by $0.09. Trevi Therapeutics has generated ($0.29) earnings per share over the last year (($0.29) diluted earnings per share). Earnings for Trevi Therapeutics are expected to decrease in the coming year, from ($0.39) to ($0.46) per share. Trevi Therapeutics has confirmed that its next quarterly earnings report will be published on Tuesday, May 7th, 2024. Trevi Therapeutics will be holding an earnings conference call on Tuesday, May 7th at 4:30 PM Eastern. Interested parties can register for or listen to the call.. Read More Trevi Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/7/2024Confirmed)-($0.09)----- 3/20/2024Q4 2023($0.10)($0.08)+$0.02($0.08)--11/9/2023Q3 2023($0.09)($0.08)+$0.01($0.08)--8/10/2023Q2 2023($0.09)($0.07)+$0.02($0.07)--5/11/2023Q1 2023($0.08)($0.06)+$0.02($0.06)--3/16/2023Q4 2022($0.11)($0.06)+$0.05($0.06)--11/10/2022Q3 2022($0.15)($0.12)+$0.03($0.12)-- Get the Latest News and Ratings for TRVI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Trevi Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/11/2022Q2 2022($0.21)($0.14)+$0.07($0.14)--5/12/2022Q1 2022($0.31)($0.24)+$0.07($0.24)-- 3/17/2022Q4 2021($0.34)($0.28)+$0.06($0.28)-- 11/10/2021Q3 2021($0.33)($0.34)($0.01)($0.34)-- 8/12/2021Q2 2021($0.46)($0.49)($0.03)($0.49)--5/13/2021Q1 2021($0.49)($0.43)+$0.06($0.43)-- Trevi Therapeutics Earnings - Frequently Asked Questions When is Trevi Therapeutics's earnings date? Trevi Therapeutics has confirmed that its next quarterly earnings data will be published on Tuesday, May 7th, 2024. Learn more on TRVI's earnings history. Did Trevi Therapeutics beat their earnings estimates last quarter? In the previous quarter, Trevi Therapeutics (NASDAQ:TRVI) reported $0.00 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.09) by $0.09. Learn more on analysts' earnings estimate vs. TRVI's actual earnings. How can I listen to Trevi Therapeutics's earnings conference call? The conference call for Trevi Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How much profit does Trevi Therapeutics generate each year? Trevi Therapeutics (NASDAQ:TRVI) has a recorded net income of -$29.07 million. TRVI has generated -$0.29 earnings per share over the last four quarters. What is Trevi Therapeutics's EPS forecast for next year? Trevi Therapeutics's earnings are expected to decrease from ($0.39) per share to ($0.46) per share in the next year. More Earnings Resources from MarketBeat Related Companies: ZVRA Earnings DSGN Earnings ACRV Earnings VERU Earnings GTHX Earnings PRLD Earnings ELYM Earnings LFCR Earnings QURE Earnings ALIM Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:TRVI) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersThe best inflation-proof investment DTIAI “wealth window” is closing June 25thParadigm PressCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsMissed NVDA? Buy this AI stock NOWChaikin AnalyticsElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trevi Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
